Icon Wealth Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Icon Wealth Partners, LLC

  • $878 Million
  • Q3 2023

A detailed history of Icon Wealth Partners, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Icon Wealth Partners, LLC holds 336 shares of REGN stock, worth $353,216. This represents 0.03% of its overall portfolio holdings.

Number of Shares
336
Previous 336 -0.0%
Holding current value
$353,216
Previous $241,000 14.52%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
BUY
$700.03 - $830.35 $4,200 - $4,982
6 Added 1.82%
336 $241,000
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $38,787 - $47,137
-57 Reduced 14.73%
330 $271,000
Q2 2022

Jul 19, 2022
SELL
$548.35 - $738.84 $35,094 - $47,285
-64 Reduced 14.19%
387 $229,000
Q1 2022

Apr 19, 2022
SELL
$595.12 - $698.43 $7,141 - $8,381
-12 Reduced 2.59%
451 $315,000
Q4 2021

Jan 19, 2022
SELL
$543.48 - $670.97 $3,260 - $4,025
-6 Reduced 1.28%
463 $292,000
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $1,148 - $1,361
-2 Reduced 0.42%
469 $284,000
Q2 2021

Jul 30, 2021
SELL
$472.8 - $558.54 $2,836 - $3,351
-6 Reduced 1.26%
471 $263,000
Q1 2021

Apr 26, 2021
SELL
$446.73 - $548.2 $1.3 Million - $1.59 Million
-2,902 Reduced 85.88%
477 $226,000
Q4 2020

Feb 08, 2021
BUY
$478.3 - $607.98 $295,589 - $375,731
618 Added 22.38%
3,379 $1.63 Million
Q3 2020

Oct 22, 2020
BUY
$544.75 - $658.21 $1.14 Million - $1.38 Million
2,095 Added 314.56%
2,761 $1.55 Million
Q2 2020

Jul 14, 2020
BUY
$493.32 - $643.92 $3,453 - $4,507
7 Added 1.06%
666 $415,000
Q1 2020

Apr 17, 2020
BUY
$336.18 - $494.43 $8,068 - $11,866
24 Added 3.78%
659 $322,000
Q4 2019

Jan 29, 2020
BUY
$274.13 - $376.51 $174,072 - $239,083
635 New
635 $238,000
Q2 2019

Aug 13, 2019
SELL
$299.6 - $414.82 $103,062 - $142,698
-344 Closed
0 $0
Q1 2019

May 09, 2019
BUY
$372.08 - $439.57 $11,162 - $13,187
30 Added 9.55%
344 $141,000
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $4,701 - $5,642
-14 Reduced 4.27%
314 $117,000
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $1,404 - $1,634
4 Added 1.23%
328 $133,000
Q2 2018

Aug 13, 2018
BUY
$284.6 - $344.99 $92,210 - $111,776
324 New
324 $112,000
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $65,058 - $81,118
-206 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $73,877 - $96,809
206
206 $77,000

Others Institutions Holding REGN

# of Institutions
1,463
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Icon Wealth Partners, LLC Portfolio

Follow Icon Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email